Dry Eye Assessment and Management: Feasibility Study
NCT01102257
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
23
Enrollment
INDIV
Sponsor class
Conditions
Dry Eye Syndromes
Keratoconjunctivitis Sicca
Interventions
DRUG:
Omega-3 EFA Supplement
DRUG:
Olive Oil
Sponsor
Asbell, Penny, M.D.
Collaborators
[object Object]